Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Promotion & Advertising Policy Work Is On OC Agenda; Will PAPS Be Revived?

This article was originally published in The Gray Sheet

Executive Summary

Device promotion and advertising policy development will be a key focus for CDRH's Office of Compliance during fiscal 2004, according to Director Timothy Ulatowski

You may also be interested in...



Trial Rethink: New Medical Journal Paradigm Should Factor Into Study Plans

Firms may need to become more selective in deciding which trials to conduct if a barrage of negative results are to be avoided, Robert Klepinski, president of Klepinski and DuVal, advised during a recent Regulatory Affairs Professionals Society meeting in Washington, D.

Trial Rethink: New Medical Journal Paradigm Should Factor Into Study Plans

Firms may need to become more selective in deciding which trials to conduct if a barrage of negative results are to be avoided, Robert Klepinski, president of Klepinski and DuVal, advised during a recent Regulatory Affairs Professionals Society meeting in Washington, D.

Device DTC Draft Guidance To Be Released As Part Of FDA Consumer Initiative

FDA's upcoming draft guidances on direct-to-consumer advertising will encourage more use of disease awareness ads, Associate Commissioner for External Relations Peter Pitts said Jan. 23 in a speech to the advocacy group Families USA in Washington, D.C

Related Content

UsernamePublicRestriction

Register

LL1132440

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel